Announcement notes release coincides with availability of improved drugs, while health advocates warns price puts new medicines beyond reach The World Health Organization’s first guidelines on the treatment of hepatitis C released Wednesday begin by noting that while treatment for the virus is successful for most of the people who receive it, 350,000 of those […]
But doesn’t explain how . . . When USAID Administrator Dr. Rajiv Shah went to Congress to discuss the Obama administration’s budget proposal for fiscal year 2015, he began with remarks in which he made no mention of tuberculosis and aside from a mention of “creating an AIDS-free generation,” made no mention of the global […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]